盐酸阿替卡因,CAS 登记号 23964-57-0,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于医药中间体及原料药。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。
医药中间体及原料药
每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。
本页已列出 盐酸阿替卡因 的 CAS 号:23964-57-0,可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。
主要涉及医药中间体及原料药。
来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。
Aarticaine hydrochloride · CAS 23964-57-0 · C13H21ClN2O3S. UNII QS9014Q792.
| CAS Registry Number | 23964-57-0 |
|---|---|
| PubChem CID | 32169 |
| Molecular formula | C13H21ClN2O3S |
| IUPAC name | methyl 4-methyl-3-[2-(propylamino)propanoylamino]thiophene-2-carboxylate;hydrochloride |
| UNII (FDA) | QS9014Q792 |
| Molecular Weight | 320.84 |
|---|---|
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 7 |
| Exact Mass | 320.0961414 |
| Monoisotopic Mass | 320.0961414 |
| Topological Polar Surface Area | 95.7 |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 325 |
| Reported hazard statements | H302 (80.6%), H315 (19.4%), H319 (96.8%), H335 (24.1%) |
|---|
H302 (80.6%): Harmful if swallowed [Warning Acute toxicity, oral]
H315 (19.4%): Causes skin irritation [Warning Skin corrosion/irritation]
ARTICAINE HYDROCHLORIDE; 23964-57-0; Articaine HCl; Ultracain; Septanest; Ultracaine; Ubistesine; Hoe-045; HOE 045; DTXSID2045444; HOE 40045; Hoe-40045; QS9014Q792; DTXCID0025444; 4-Methyl-3-(2-(propylamino)propionamido)-2-thiophenecarboxylic acid methyl ester HCl; 2-Thiophenecarboxylic acid, 4-methyl-3-((1-oxo-2-(propylamino)propyl)amino)-, methyl ester, monohydrochloride
CAS 23964-57-0; molecular formula C13H21ClN2O3S; molecular weight — g/mol.
ARTICAINE HYDROCHLORIDE, 23964-57-0, Articaine HCl, Ultracain, Septanest, Ultracaine.
Hazard statements reported: H302, H315, H319, H335.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.